Company Overview

Provectus Biopharmaceuticals, Inc. is a development-stage biopharmaceutical company dedicated to investigating potential therapeutics for cancer and inflammatory dermatoses.

Investor Contacts

Our Contact Form Mailing Address

Telephone: +1 (866) 594-5999
Fax: +1 (866) 998-0005
info@pvct.com

Provectus Biopharmaceuticals, Inc.
7327 Oak Ridge Hwy
Knoxville, TN 37931 USA

Investor Relations Media Relations

Provectus Biopharmaceuticals, Inc.
Email: investorrelations@pvct.com
Phone: +1 (866) 594-5999

Allison+Partners
Todd Aydelotte,
Managing Director
71 Fifth Avenue, 7th Floor
New York, NY 10003
Telephone: 646.428.0644

Transfer Agent Investment Advisor

(i.e. stockholder records, transfer, change of address, etc.)
Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, NY 11717
E-mail: shareholder@broadridge.com
Telephone: +1 (877) 830-4936
Fax: +1 (215) 553-5402

Network 1 Financial Securities
Damon Testaverde
Telephone: +1 (800) 205-8031

Stock Performance

Today's Open 0.03
Volume 308,110
Day Range 0.03 - 0.03
52 Week Range 0.01 - 0.39
Bid/Ask 0.03 / 0.03
Bid/Ask Size 100,000 X 10,000
Previous Close 0.03
Market Cap 6.17 million
Shares Outstanding 212.83 million
Dividend/Yield 0.00 / 0.00%
EPS (TTM) -0.14
P/E Ratio (TTM) N/A

Recent XBRL Filings

Filing Date Form Type Description View
May 10, 2017 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Mar 31, 2017 10-K Annual report htmlhtml   pdfpdf   xbrlxbrl  
Nov 09, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
Aug 09, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl  
May 10, 2016 10-Q Quarterly report htmlhtml   pdfpdf   xbrlxbrl